Apigenin inhibits TNFα/IL-1α-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells

PLoS ONE

Volumn 12, Issue 4, 2017, Pages

  Bauer, David ^a   Redmon, Natalie ^a   Mazzio, Elizabeth ^a   Soliman, Karam F ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CCL2 PROTEIN, HUMAN; I KAPPA B KINASE; IKBKE PROTEIN, HUMAN; IL1A PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER MORTALITY; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; BREAST; BREAST NEOPLASMS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; FEMALE; IMMUNOLOGY; PATHOLOGY; PETROSELINUM; TUMOR CELL LINE;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APIGENIN; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOKINE CCL2; FEMALE; HUMANS; I-KAPPA B KINASE; INTERLEUKIN-1ALPHA; PETROSELINUM; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85018853037     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0175558     Document Type: Article

References (67)

1. Chen SS, Corteling R, Stevanato L, Sinden J (2012) Polyphenols inhibit indoleamine 3, 5-dioxygenase- 1 enzymatic activitya role of immunomodulation in chemoprevention. Discov Med 14: 327-333. PMID: 23200064.
2. Common spice may slow Alzheimer's. Health News 11: 2.
3. Xu Y, Xin Y, Diao Y, Lu C, Fu J, et al. (2011) Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells. PLoS One 6: e29169. https://doi.org/10.1371/journal.pone.0029169 PMID: 22216199.
4. Ferrucci V, Boffa I, De Masi G, Zollo M (2016) Natural compounds for pediatric cancer treatment. Naunyn Schmiedebergs Arch Pharmacol 389: 131-149. https://doi.org/10.1007/s00210-015-1191-5 PMID: 26650503.
5. Angelini A, Di Ilio C, Castellani ML, Conti P, Cuccurullo F (2010) Modulation of multidrug resistance pglycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MESSA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. J Biol Regul Homeost Agents 24: 197-205. PMID: 20487633.
6. Mafuvadze B, Benakanakere I, Hyder SM (2010) Apigenin blocks induction of vascular endothelial growth factor mRNA and protein in progestin-Treated human breast cancer cells. Menopause 17: 1055-1063. https://doi.org/10.1097/gme.0b013e3181dd052f PMID: 20551847.
7. Mafuvadze B, Liang Y, Besch-Williford C, Zhang X, Hyder SM (2012) Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors. Horm Cancer 3: 160-171. https://doi.org/10.1007/s12672-012-0114-xPMID: 22569706.
8. Tseng TH, Chien MH, Lin WL, Wen YC, Chow JM, et al. (2016) Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation- mediated p21WAF1/CIP1 expression. Environ Toxicol.
9. Seo HS, Ku JM, Choi HS, Woo JK, Jang BH, et al. (2015) Apigenin induces caspase-dependent apoptosis by inhibiting signal transducer and activator of transcription 3 signaling in HER2-overexpressing SKBR3 breast cancer cells. Mol Med Rep 12: 2977-2984. https://doi.org/10.3892/mmr.2015.3698 PMID: 25936427.
10. Choi EJ, Kim GH (2009) Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells. J Nutr Biochem 20: 285-290. https://doi.org/10.1016/j.jnutbio.2008.03.005 PMID: 18656338.
11. Lin CH, Chang CY, Lee KR, Lin HJ, Chen TH, et al. (2015) Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway. BMC Cancer 15: 958. https://doi.org/10.1186/s12885-015-1965-7 PMID: 26675309.
12. Choi EJ, Kim GH (2009) Apigenin Induces Apoptosis through a Mitochondria/Caspase-Pathway in Human Breast Cancer MDA-MB-453 Cells. J Clin Biochem Nutr 44: 260-265. https://doi.org/10.3164/jcbn.08-230 PMID: 19430615.
13. Harrison ME, Power Coombs MR, Delaney LM, Hoskin DW (2014) Exposure of breast cancer cells to a subcytotoxic dose of apigenin causes growth inhibition, oxidative stress, and hypophosphorylation of Akt. Exp Mol Pathol 97: 211-217. https://doi.org/10.1016/j.yexmp.2014.07.006 PMID: 25019465.
14. Seo HS, Ju JH, Jang K, Shin I (2011) Induction of apoptotic cell death by phytoestrogens by up-regulating the levels of phospho-p53 and p21 in normal and malignant estrogen receptor alpha-negative breast cells. Nutr Res 31: 139-146. https://doi.org/10.1016/j.nutres.2011.01.011 PMID: 21419318.
15. Cao X, Liu B, Cao W, Zhang W, Zhang F, et al. (2013) Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells. Chin J Cancer Res 25: 212-222. https://doi.org/10.3978/j.issn.1000-9604.2013.04.01 PMID: 23592903.
16. Seo HS, Jo JK, Ku JM, Choi HS, Choi YK, et al. (2015) Induction of caspase-dependent extrinsic apoptosis by apigenin through inhibition of signal transducer and activator of transcription 3 (STAT3) signalling in HER2-overexpressing BT-474 breast cancer cells. Biosci Rep 35.
17. Seo HS, Choi HS, Kim SR, Choi YK, Woo SM, et al. (2012) Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFkappaB signaling in HER2-overexpressing breast cancer cells. Mol Cell Biochem 366: 319-334. https://doi.org/10.1007/s11010-012-1310-2 PMID: 22527937.
18. Nabavi SM, Habtemariam S, Daglia M, Nabavi SF (2015) Apigenin and Breast Cancers: From Chemistry to Medicine. Anticancer Agents Med Chem 15: 728-735. PMID: 25738871.
19. van Meeuwen JA, Korthagen N, de Jong PC, Piersma AH, van den Berg M (2007) (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture. Toxicol Appl Pharmacol 221: 372-383. https://doi.org/10.1016/j.taap.2007.03.016 PMID: 17482226.
20. Noolu B, Gogulothu R, Bhat M, Qadri SS, Reddy VS, et al. (2016) In Vivo Inhibition of Proteasome Activity and Tumour Growth by Murraya koenigii Leaf Extract in Breast Cancer Xenografts and by its active flavonoids in breast cancer cells. Anticancer Agents Med Chem.
21. Chen D, Landis-Piwowar KR, Chen MS, Dou QP (2007) Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. Breast Cancer Res 9: R80. https://doi.org/10.1186/bcr1797 PMID: 18300387.
22. Wang QR, Yao XQ, Wen G, Fan Q, Li YJ, et al. (2011) Apigenin suppresses the growth of colorectal cancer xenografts via phosphorylation and up-regulated FADD expression. Oncol Lett 2: 43-47. https://doi.org/10.3892/ol.2010.215PMID: 22870126.
23. Liu D, Wang X, Chen Z (2016) Tumor Necrosis Factor-Alpha, a Regulator and Therapeutic Agent on Breast Cancer. Curr Pharm Biotechnol 17: 486-494. PMID: 26927216.
24. Katanov C, Lerrer S, Liubomirski Y, Leider-Trejo L, Meshel T, et al. (2015) Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-Alpha and the NF-kappaB pathway. Stem Cell Res Ther 6: 87. https://doi.org/10.1186/s13287-015-0080-7PMID: 25928089.
25. Trivanovic D, Jaukovic A, Krstic J, Nikolic S, Okic Djordjevic I, et al. (2016) Inflammatory cytokines prime adipose tissue mesenchymal stem cells to enhance malignancy of MCF-7 breast cancer cells via transforming growth factor-beta1. IUBMB Life 68: 190-200. https://doi.org/10.1002/iub.1473PMID: 26805406.
26. Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, et al. (2011) Inflammatory mediators in breast cancer: coordinated expression of TNFalpha & IL-1beta with CCL2 & CCL5 and effects on epithelial-To-mesenchymal transition. BMC Cancer 11: 130. https://doi.org/10.1186/1471-2407-11-130 PMID: 21486440.
27. Ben-Baruch A (2012) The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFalpha and Chemokines. Cancer Microenviron 5: 151-164. https://doi.org/10.1007/s12307-011-0094-3 PMID: 22190050.
28. Papi A, Storci G, Guarnieri T, De Carolis S, Bertoni S, et al. (2013) Peroxisome proliferator activated receptor-Alpha/hypoxia inducible factor-1alpha interplay sustains carbonic anhydrase IX and apoliprotein E expression in breast cancer stem cells. PLoS One 8: e54968. https://doi.org/10.1371/journal.pone.0054968 PMID: 23372804.
29. Steiner JL, Murphy EA (2012) Importance of chemokine (CC-motif) ligand 2 in breast cancer. Int J Biol Markers 27: e179-e185. https://doi.org/10.5301/JBM.2012.9345 PMID: 22865298.
30. Vrakas CN, O'Sullivan RM, Evans SE, Ingram DA, Jones CB, et al. (2015) The Measure of DAMPs and a role for S100A8 in recruiting suppressor cells in breast cancer lung metastasis. Immunol Invest 44: 174-188. https://doi.org/10.3109/08820139.2014.952818 PMID: 25255046.
31. Tabaries S, Ouellet V, Hsu BE, Annis MG, Rose AA, et al. (2015) Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases. Breast Cancer Res 17: 45. https://doi.org/10.1186/s13058-015-0558-3PMID: 25882816.
32. Ibrahim SA, Katara GK, Kulshrestha A, Jaiswal MK, Amin MA, et al. (2015) Breast cancer associated a2 isoform vacuolar ATPase immunomodulates neutrophils: potential role in tumor progression. Oncotarget 6: 33033-33045. https://doi.org/10.18632/oncotarget.5439 PMID: 26460736.
33. Kindlund B, Sjoling A, Yakkala C, Adamsson J, Janzon A, et al. (2016) CD4 regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-beta. Gastric Cancer.
34. Mishra P, Banerjee D, Ben-Baruch A (2011) Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukoc Biol 89: 31-39. https://doi.org/10.1189/jlb.0310182 PMID: 20628066.
35. Ueno T, Toi M, Saji H, Muta M, Bando H, et al. (2000) Significance of macrophage chemoattractant protein- 1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6: 3282-3289. PMID: 10955814.
36. Chun E, Lavoie S, Michaud M, Gallini CA, Kim J, et al. (2015) CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function. Cell Rep 12: 244-257. https://doi.org/10.1016/j.celrep.2015.06.024 PMID: 26146082.
37. McClellan JL, Davis JM, Steiner JL, Enos RT, Jung SH, et al. (2012) Linking tumor-Associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1. Am J Physiol Gastrointest Liver Physiol 303: G1087-G1095. https://doi.org/10.1152/ajpgi.00252.2012PMID:23019193.
38. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, et al. (2011) CCL2 recruits inflammatory monocytes to facilitate breast-Tumour metastasis. Nature 475: 222-225. https://doi.org/10.1038/nature10138 PMID: 21654748.
39. Barbie TU, Alexe G, Aref AR, Li S, Zhu Z, et al. (2014) Targeting an IKBKE cytokine network impairs triple- negative breast cancer growth. J Clin Invest 124: 5411-5423. https://doi.org/10.1172/JCI75661 PMID: 25365225.
40. Jiang Z, Liu JC, Chung PE, Egan SE, Zacksenhaus E (2014) Targeting HER2(+) breast cancer: The TBK1/IKKepsilon axis. Oncoscience 1: 180-182. https://doi.org/10.18632/oncoscience.18 PMID: 25594009.
41. Fujimoto H, Sangai T, Ishii G, Ikehara A, Nagashima T, et al. (2009) Stromal MCP-1 in mammary tumors induces tumor-Associated macrophage infiltration and contributes to tumor progression. Int J Cancer 125: 1276-1284. https://doi.org/10.1002/ijc.24378 PMID: 19479998.
42. Malek E, de Lima M, Letterio JJ, Kim BG, Finke JH, et al. (2016) Myeloid-derived suppressor cells: The green light for myeloma immune escape. Blood Rev.
43. Zhou SL, Zhou ZJ, Hu ZQ, Huang XW, Wang Z, et al. (2016) Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib. Gastroenterology.
44. Wang Y, Liu T, Tang W, Deng B, Chen Y, et al. (2016) Hepatocellular Carcinoma Cells Induce Regulatory T Cells and Lead to Poor Prognosis via Production of Transforming Growth Factor-beta1. Cell Physiol Biochem 38: 306-318. https://doi.org/10.1159/000438631 PMID: 26799063.
45. Sun L, Jin H, Li H (2016) GARP: A surface molecule of regulatory T cells that is involved in the regulatory function and TGF-beta releasing. Oncotarget.
46. Rego SL, Helms RS, Dreau D (2014) Breast tumor cell TACE-shed MCSF promotes pro-Angiogenic macrophages through NF-kappaB signaling. Angiogenesis 17: 573-585. https://doi.org/10.1007/s10456-013-9405-2PMID: 24197832.
47. Kitamura T, Qian BZ, Soong D, Cassetta L, Noy R, et al. (2015) CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-Associated macrophages. J Exp Med 212: 1043-1059. https://doi.org/10.1084/jem.20141836 PMID: 26056232.
48. Shen RR, Zhou AY, Kim E, Lim E, Habelhah H, et al. (2012) IkappaB kinase epsilon phosphorylates TRAF2 to promote mammary epithelial cell transformation. Mol Cell Biol 32: 4756-4768. https://doi.org/10.1128/MCB.00468-12 PMID: 23007157.
49. Guo JP, Coppola D, Cheng JQ (2011) IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation. J Biol Chem 286: 37389-37398. https://doi.org/10.1074/jbc.M111.287433 PMID: 21908616.
50. Zhou AY, Shen RR, Kim E, Lock YJ, Xu M, et al. (2013) IKKepsilon-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex. Cell Rep 3: 724- 733. https://doi.org/10.1016/j.celrep.2013.01.031 PMID: 23453969.
51. Shukla S, Shankar E, Fu P, MacLennan GT, Gupta S (2015) Suppression of NF-kappaB and NF-kappaB- Regulated Gene Expression by Apigenin through IkappaBalpha and IKK Pathway in TRAMP Mice. PLoS One 10: e0138710. https://doi.org/10.1371/journal.pone.0138710 PMID: 26379052.
52. Shukla S, Kanwal R, Shankar E, Datt M, Chance MR, et al. (2015) Apigenin blocks IKKalpha activation and suppresses prostate cancer progression. Oncotarget 6: 31216-31232. https://doi.org/10.18632/oncotarget.5157 PMID: 26435478.
53. Mirzoeva S, Franzen CA, Pelling JC (2014) Apigenin inhibits TGF-beta-induced VEGF expression in human prostate carcinoma cells via a Smad2/3-And Src-dependent mechanism. Mol Carcinog 53: 598-609. https://doi.org/10.1002/mc.22005 PMID: 23359392.
54. Chunhua L, Donglan L, Xiuqiong F, Lihua Z, Qin F, et al. (2013) Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT. J Nutr Biochem 24: 1766-1775. https://doi.org/10.1016/j.jnutbio.2013.03.006 PMID: 23773626.
55. Moses K, Brandau S (2016) Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells. Semin Immunol.
56. Yan C, Huo X, Wang S, Feng Y, Gong Z (2015) Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish. J Hepatol 63: 420-428. https://doi.org/10.1016/j.jhep.2015.03.024 PMID: 25828472.
57. Deryugina EI, Zajac E, Juncker-Jensen A, Kupriyanova TA, Welter L, et al. (2014) Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment. Neoplasia 16: 771-788. https://doi.org/10.1016/j.neo.2014.08.013 PMID: 25379015.
58. Jehs T, Faber C, Juel HB, Bronkhorst IH, Jager MJ, et al. (2014) Inflammation-induced chemokine expression in uveal melanoma cell lines stimulates monocyte chemotaxis. Invest Ophthalmol Vis Sci 55: 5169-5175. https://doi.org/10.1167/iovs.14-14394 PMID: 25074768.
59. Schmall A, Al-Tamari HM, Herold S, Kampschulte M, Weigert A, et al. (2015) Macrophage and cancer cell cross-Talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer. Am J Respir Crit Care Med 191: 437-447. https://doi.org/10.1164/rccm.201406-1137OC PMID: 25536148.
60. Hollmen M, Roudnicky F, Karaman S, Detmar M (2015) Characterization of macrophagecancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer. Sci Rep 5: 9188. https://doi.org/10.1038/srep09188PMID: 25776849.
61. Yumimoto K, Akiyoshi S, Ueo H, Sagara Y, Onoyama I, et al. (2015) F-box protein FBXW7 inhibits cancer metastasis in a non-cell-Autonomous manner. J Clin Invest 125: 621-635. https://doi.org/10.1172/JCI78782 PMID: 25555218.
62. Choi HJ, Choi HJ, Chung TW, Ha KT (2016) Luteolin inhibits recruitment of monocytes and migration of Lewis lung carcinoma cells by suppressing chemokine (C-C motif) ligand 2 expression in tumor-Associated macrophage. Biochem Biophys Res Commun 470: 101-106. https://doi.org/10.1016/j.bbrc.2016.01.002 PMID: 26766793.
63. Kimura Y, Sumiyoshi M (2015) Antitumor and antimetastatic actions of dihydroxycoumarins (esculetin or fraxetin) through the inhibition of M2 macrophage differentiation in tumor-Associated macrophages and/or G1 arrest in tumor cells. Eur J Pharmacol 746: 115-125. https://doi.org/10.1016/j.ejphar.2014.10.048 PMID: 25445053.
64. Devaud C, John LB, Westwood JA, Yong CS, Beavis PA, et al. (2015) Cross-Talk between tumors can affect responses to therapy. Oncoimmunology 4: e975572. https://doi.org/10.4161/2162402X.2014.975572 PMID: 26140251.
65. Zollo M, Di Dato V, Spano D, De Martino D, Liguori L, et al. (2012) Targeting monocyte chemotactic protein- 1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models. Clin Exp Metastasis 29: 585-601. https://doi.org/10.1007/s10585-012-9473-5 PMID: 22484917.
66. Jang JY, Lee JK, Jeon YK, Kim CW (2013) Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-Associated macrophage infiltration and M2 polarization. BMC Cancer 13: 421. https://doi.org/10.1186/1471-2407-13-421 PMID: 24044575.
67. Shukla S, Gupta S (2010) Apigenin: A promising molecule for cancer prevention. Pharm Res 27: 962- 978. https://doi.org/10.1007/s11095-010-0089-7 PMID: 20306120.